Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas

Immunoglobulin M: Restrainer of Inflammation and Mediator of Immune Evasion by Plasmodium falciparum Malaria

(2016) Richard J. Pleass et al.   TRENDS IN PARASITOLOGY

Is Fc gamma receptor IIA (FcγRIIA) polymorphism associated with clinical malaria and Plasmodium falciparum specific antibody levels in children from Burkina Faso?

(2015) Mariama K. Cherif et al.   ACTA TROPICA

Multiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity

(2015) Josea Rono et al.   BMC Medicine

Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation

(2014) Kwadwo A Kusi et al.   MALARIA JOURNAL

Fc Gamma Receptor 3B (FCGR3B-c.233C>A-rs5030738) Polymorphism Modifies the Protective Effect of Malaria Specific Antibodies in Ghanaian Children

(2013) Bright Adu et al.   JOURNAL OF INFECTIOUS DISEASES

Fc Gamma Receptor IIIB (FcγRIIIB) Polymorphisms Are Associated with Clinical Malaria in Ghanaian Children

(2012) Bright Adu et al.   PLoS One

Serological Markers Suggest Heterogeneity of Effectiveness of Malaria Control Interventions on Bioko Island, Equatorial Guinea

(2011) Jackie Cook et al.   PLoS One

A Malaria Vaccine Based on the Polymorphic Block 2 Region of MSP-1 that Elicits a Broad Serotype-Spanning Immune Response

(2011) Graeme J. M. Cowan et al.   PLoS One

Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria?

(2010) I. Nebie et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

The Plasmodium falciparum-Specific Human Memory B Cell Compartment Expands Gradually with Repeated Malaria Infections

(2010) Greta E. Weiss et al.   PLoS Pathogens

Acquired Immunity to Malaria

(2009) D. L. Doolan et al.   CLINICAL MICROBIOLOGY REVIEWS

Immunoglobulin G Subclass-Specific Responses against Plasmodium falciparum Merozoite Antigens Are Associated with Control of Parasitemia and Protection from Symptomatic Illness

(2009) D. I. Stanisic et al.   INFECTION AND IMMUNITY

Anti–MSP1 Block 2 Antibodies Are Effective at Parasite Killing in an Allele‐Specific Manner by Monocyte‐Mediated Antibody‐Dependent Cellular Inhibition

(2009) Corine Demanga Galamo et al.   JOURNAL OF INFECTIOUS DISEASES

Plasmodium falciparum genotypes diversity in symptomatic malaria of children living in an urban and a rural setting in Burkina Faso

(2009) Issiaka Soulama et al.   MALARIA JOURNAL

Rapid Assessment of Malaria Transmission Using Age-Specific Sero-Conversion Rates

(2009) Laveta Stewart et al.   PLoS One

Differences in Human Antibody Reactivity to Plasmodium falciparum Variant Surface Antigens Are Dependent on Age and Malaria Transmission Intensity in Northeastern Tanzania

(2008) L. S. Vestergaard et al.   INFECTION AND IMMUNITY

Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria

(2008) F. H. A. Osier et al.   INFECTION AND IMMUNITY

Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis

(2008) Serign J Ceesay et al.   LANCET

Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya

(2008) Wendy P O'Meara et al.   LANCET

Dried blood spots as a source of anti-malarial antibodies for epidemiological studies

(2008) Patrick H Corran et al.   MALARIA JOURNAL

Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children

(2008) Daniel Dodoo et al.   MALARIA JOURNAL

Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya

(2008) George W. Agak et al.   VACCINE